Stay updated on Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial

Sign up to get notified when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A unified 'Locations' section lists sites in California, New Jersey, and New York; prior 'California Locations', 'New Jersey Locations', and 'New York Locations' sections were removed, and the revision version updated from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:31:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.0%
    Check dated 2025-11-24T21:13:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice banner. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:38:29.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The updates preserve the study details, eligibility criteria, and outcomes, with only minor layout and formatting changes evident on the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:11:10.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Core content updated to reflect current operating status and official references; version bumped from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T01:53:21.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Upgrade version from v3.0.2 to v3.1.0 with an added update marker; no substantive content or critical data changes detected.
    Difference
    0.4%
    Check dated 2025-09-28T23:28:36.000Z thumbnail image

Stay in the know with updates to Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.